Publication:
Preliminary studies of Volten VR4® Kaempferia parviflora herb extracts on blood glucose levels in human type-2 diabetes mellitus and its mineral element analysis

dc.contributor.authorAhmad Sabry Mohamad,en_US
dc.contributor.authorMuhammad Noor Nordin,en_US
dc.contributor.authorIsmail Che Ani,en_US
dc.contributor.authorJohan Jemberang,en_US
dc.contributor.authorReezal Ishak,en_US
dc.contributor.authorAhmad Najib Hasan,en_US
dc.contributor.authorMuhammad Imran Ahmad,en_US
dc.contributor.authorMohd Rahman Omaren_US
dc.contributor.authorRoszymah Hamzahen_US
dc.date.accessioned2024-05-27T14:34:23Z
dc.date.available2024-05-27T14:34:23Z
dc.date.issued2021
dc.date.submitted2022-1-27
dc.descriptionVolume 67 (2021) - Issue 4 (December 2021)en_US
dc.description.abstractVolten VR4® capsules containing herb extract of Kaempferia parviflora has been claimed to reduce blood glucose in patients with diabetes. This preliminary study is conducted to evaluate the efficacy of Volten VR4® on healthy individuals and type-2 diabetes mellitus volunteers. The extracts of 400 mg capsules of Kaempferia parviflora (KP) were used to measure the blood glucose level of 2-hour postprandial. The healthy group consists of 15 young adults aged 20-30 with no history of serious diseases, while the diabetic group includes 12 individuals aged 35-75 diagnosed with type-2 diabetes mellitus. Data were validated through the Willcoxon and Friedman test statistics and error distribution. The investigation was continued to trace the capsules contents of elements using inductively coupled plasma optical emission spectrometry (ICP-OES) techniques. It has been shown that KP reducing blood sugar levels has been associated with flavonoids and methoxyflavones components. The result specifically showed that consuming VR4® capsules can significantly reduce blood glucose, either at the state of fasting or postprandially. In the study the content of mineral and heavy metal elements in VR4® capsules has been evaluated. Volten VR4® Kaempferia parviflora extract is safe to be consumed at a single dose of 400 mg. The study also has shown that the participants are free from adverse reactions and hypoglycaemia.en_US
dc.identifier.citationMohamad, Ahmad Sabry, Nordin, Muhammad Noor, Ani, Ismail Che, Jemberang, Johan, Ishak, Reezal, Hasan, Ahmad Najib, Ahmad, Muhammad Imran, Omar, Mohd Rahman and Hamzah, Roszymah. "Preliminary studies of Volten VR4® Kaempferia parviflora herb extracts on blood glucose levels in human type-2 diabetes mellitus and its mineral element analysis" Herba Polonica, vol.67, no.4, 2021, pp.42-53. https://doi.org/10.2478/hepo-2021-0021en_US
dc.identifier.doi10.2478/hepo-2021-0021
dc.identifier.epage53
dc.identifier.issn0018-0599
dc.identifier.issue4
dc.identifier.other971-15
dc.identifier.spage42
dc.identifier.urihttps://www.sciendo.com/article/10.2478/hepo-2021-0021
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/3183
dc.identifier.volume67
dc.language.isoenen_US
dc.publisherPolish Ministry of Science and Higher Educationen_US
dc.relation.ispartofHERBA POLONICAen_US
dc.subjectKaempferia parviflorablood glucosetype-2 diabetes mellitusflavonoidsen_US
dc.titlePreliminary studies of Volten VR4® Kaempferia parviflora herb extracts on blood glucose levels in human type-2 diabetes mellitus and its mineral element analysisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Preliminary studies of Volten VR4® Kaempferia parviflora herb extracts on blood glucose levels in human type-2 diabetes mellitus and its mineral element analysis.pdf
Size:
3.24 MB
Format:
Adobe Portable Document Format